U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Anticoagulant Sodium Citrate 4% w/v Solution, USP
  1. Approved Blood Products

Anticoagulant Sodium Citrate 4% w/v Solution, USP

Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P.
Manufacturer: Haemonetics Corporation, Braintree, MA
Indication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures
Approval Date: 3/3/2000
Type of submission: New Drug Application

Supporting Documents

Back to Top